Skip to main content
. 2024 Jan 12;14:1157. doi: 10.1038/s41598-024-51455-3

Figure 2.

Figure 2

Subgroup analysis for the risk of (A) Crohn’s disease and (B) ulcerative colitis in patents with migraine compared to control groups.